Results 321 to 330 of about 187,113 (345)
Some of the next articles are maybe not open access.
Epidemiology of Non-Alcoholic Fatty Liver Disease
Digestive Diseases, 2010Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20–30%. About 2–3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the
Bellentani S. +3 more
openaire +2 more sources
Liver transplantation for non-alcoholic fatty liver disease
Minerva Gastroenterology, 2018Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome, and it is defined by the presence of steatosis in >5% of hepatocytes, according to histological analysis or detected by specific proton density fat fraction obtained magnetic resonance imaging.
Giacomo, Germani, Chiara, Becchetti
openaire +2 more sources
Non-alcoholic fatty liver disease
Paediatrics and Child Health, 2013Abstract Non-alcoholic fatty liver disease is rapidly becoming one of most common liver diseases in the paediatric population in industrialized countries due to the growing prevalence of obesity and overweight. Paediatric NAFLD is typically of primary origin and it is strongly associated with several features of the metabolic syndrome. The mainstay of
Claudia Della Corte +4 more
openaire +1 more source
Health insurance status and cancer stage at diagnosis and survival in the United States
Ca-A Cancer Journal for Clinicians, 2022Jingxuan Zhao +2 more
exaly
Non-alcoholic fatty liver disease
Spravočnik vrača obŝej praktiki (Journal of Family Medicine)Fatty degeneration of cells under the influence of various factors is called steatosis; most often this process is observed in the pancreas and liver. Steatosis of the liver means its fatty infiltration, in which fatty inclusions appear in the parenchyma of the organ, leading to disruption of the hepatocyte function. Steatosis can be focal and diffuse;
openaire +1 more source
The gut–liver axis and gut microbiota in health and liver disease
Nature Reviews Microbiology, 2023Cynthia Li-Shin Hsu, Bernd Schnabl
exaly
Immunotherapies for hepatocellular carcinoma
Nature Reviews Clinical Oncology, 2021, Florian Castet, Mala K Maini
exaly